InnoCare Pharma Limited (33C.STU) Q2 2026 Earnings

23AprConfirmed
Q4 2025
Q2 2026
-0
0
0
0.01

Details

Expected EPS
N/A
Actual EPS
0.007442126514
Surprise EPS
0.01
Surprise Percent
+∞%

Description

InnoCare Pharma Limited (33C.STU) has reported earnings of 0.007442126514 per share for Q2 2026.

0 Comments

Share your thoughts